South Korea Reports Rising Antibiotic Resistance at Smaller Hospitals and Clinics

South Korea Reports Rising Antibiotic Resistance at Smaller Hospitals and Clinics

Image to help understand the article

South Korea’s public health agency has reported sharp increases in antibiotic resistance among several major pathogens at smaller hospitals, long-term care hospitals and clinics, even as resistance rates declined slightly at general hospitals.

The Korea Disease Control and Prevention Agency released its 2025 national report on antimicrobial-resistant bacteria after analyzing pathogens isolated from six types of patient specimens, including blood and urine. The survey, conducted under South Korea’s infectious disease law, also examined clinical information and resistance to individual antibiotics.

Drug-resistant infections rise outside general hospitals

At general hospitals, resistance declined slightly among several major causes of bloodstream infections, including third-generation cephalosporin-resistant Klebsiella pneumoniae, carbapenem-resistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii. Overall resistance levels at those hospitals remained high, however.

Long-term care hospitals generally recorded higher resistance rates among major bloodstream pathogens than other types of medical facilities.

Resistance rose broadly from the previous year at small and midsize hospitals, long-term care hospitals and clinics. The most pronounced increases involved carbapenem-resistant Klebsiella pneumoniae, a difficult-to-treat intestinal bacterium. Its resistance rate at small and midsize hospitals climbed from 17.4% in 2024 to 32.8% in 2025. The rate rose from 47.7% to 60.4% at long-term care hospitals and from 10.4% to 25.5% at clinics.

National surveillance data combined

The annual report includes antibiotic susceptibility test results by type of medical institution. A resistant result means treatment is unlikely to work at the recommended dosage, while an intermediate result indicates the drug may work depending on the infection site or how it is administered. Susceptibility means treatment is expected to be effective under recommended use.

South Korea operates separate surveillance programs covering general hospitals; smaller hospitals, long-term care facilities and clinics; and legally designated infectious diseases. Since 2016, the national antimicrobial resistance survey has monitored 10 regional general hospitals under World Health Organization standards.

The agency has published annual data on resistance by facility and pathogen, as well as trends in multidrug-resistant bacteria, since 2017. This year’s report integrates data from general hospitals, smaller hospitals and clinics and includes regional resistance patterns for major pathogens.

KDCA Commissioner Lim Seung-kwan said the agency hopes the report will help health care providers understand antimicrobial resistance in South Korea, improve antibiotic use and develop more effective measures to manage resistance. The report is available on the agency’s website.

Source: Original Korean article - Trendy News Korea

Comments